4408|380|Public
25|$|Filgrastim or pegfilgrastim {{help with}} {{white blood cell}} counts and {{neutrophil}} counts. Blood transfusions and epoetin alfa help with anemia. Computational analysis on panel of Osteosarcoma cell lines identified new shared and specific therapeutic targets(proteomic and genetic) in Osteosarcoma phenotypes showed increased role of <b>tumor</b> <b>microenvironment.</b>|$|E
25|$|Checkpoint therapy uses {{antibodies}} {{and other}} techniques {{to circumvent the}} defenses that tumors use to suppress the immune system. Each defense {{is known as a}} checkpoint. Compound therapies combine antibodies to suppress multiple defensive layers. Known checkpoints include CTLA-4 targeted by ipilimumab, PD-1 targeted by nivolumab and pembrolizumab and the <b>tumor</b> <b>microenvironment.</b>|$|E
25|$|EMT's {{important}} {{feature is the}} loss of membrane E-cadherin in adherens junctions, where β-catenin may play a significant role. Translocation of β-catenin from adherens junctions to the nucleus may lead to a loss of E-cadherin and subsequently to EMT. Nuclear β-catenin apparently can directly, transcriptionally activate EMT-associated target genes, such as the E-cadherin gene repressor SLUG (also known as SNAI2). Mechanical properties of the <b>tumor</b> <b>microenvironment,</b> such as hypoxia, can contribute to CSC survival and metastatic potential through stabilization of hypoxia inducible factors through interactions with ROS (reactive oxygen species).|$|E
30|$|Determining how <b>tumor</b> <b>microenvironments</b> {{regulate}} cancer initiation {{and behavior}} through interactions among cell types (e.g., initiated cells, activated stromal cells, and {{components of the}} extracellular matrix).|$|R
30|$|Searching for {{innovative}} mechanics-directed clinical interventions that {{emphasize the importance}} of the physical organization of cell-to-cell contacts, tissue architecture, <b>tumor</b> <b>microenvironments,</b> and mechanical properties in the response to therapy.|$|R
40|$|The {{divergent}} {{requirement for}} tolerance to support conception and protective response against sexually transmitted infections defines the unique immunological dynamics {{in the female}} reproductive tract (FRT). In part, these requirements are achieved by the cyclic modulation of cytolytic CD 8 T cell function in the FRT that underlie the respective immunosuppressive and immuno-competent milieus during the secretory and proliferative phases of the menstrual cycle. The CD 8 T cell function can be dampened by exposure to indoleamine 2, 3 -dioxygenase and/or arginase enzymes. Indeed, these 2 enzymes are known as primary inducers of immune suppression in <b>tumor</b> <b>microenvironments.</b> This review discusses the intriguing parallel expression of these 2 enzymes in <b>tumor</b> <b>microenvironments</b> and in the secretory endometrium. We surmise that investigating the underlying natural mechanisms that suppress and restore the immunocompetence of CD 8 T cells in the FRT each month may provide valuable insights into ways to artificially recapitulate these mechanisms and inhibit immune suppression in <b>tumor</b> <b>microenvironments...</b>|$|R
25|$|Bridging {{the fields}} of {{chemical}} engineering, oncology, pathology, biophysics, and materials science, Wirtz’s research focuses on the biophysical properties of healthy and diseased cells, including interactions between adjacent cells {{and the role of}} cellular architecture on nuclear shape and gene expression. His research interests include cell biophysics, aging, <b>tumor</b> <b>microenvironment,</b> digital pathology, the actin cap, single molecule manipulation, intracellular particle trafficking, instrument development, tissue engineering, and nanotechnology in biology and medicine. He has made important contributions to molecular and biophysical mechanisms of cell motility and adhesion and nuclear dynamics in health and disease, and he pioneered the method of particle-tracking microrheology to probe the rheological properties of complex fluids and living cells and tissues.|$|E
25|$|The <b>tumor</b> <b>microenvironment</b> (TME) {{features}} {{prevents the}} recruitment of T cells to the tumor. Ways include chemokine CCL2 nitration, which traps T cells in the stroma. Tumor vasculature helps tumors preferentially recruit other immune cells over T cells, in part through endothelial cell (EC)–specific expression of FasL, ETBR, and B7H3. Myelomonocytic and tumor cells can up-regulate expression of PD-L1, partly driven by hypoxic conditions and cytokine production, such as IFNβ. Aberrant metabolite production in the TME, such as the pathway regulation by IDO, can affect T cell functions directly and indirectly via cells such as Tregcells. CD8 cells can be suppressed by B cells regulation of TAM phenotypes. Cancer-associated fibroblasts (CAFs) have multiple TME functions, in part through extracellular matrix (ECM)–mediated T cell trapping and CXCL12-regulated T cell exclusion.|$|E
500|$|The {{most common}} form of {{pancreatic}} cancer (adenocarcinoma) is typically characterized by moderately to poorly differentiated glandular structures on microscopic examination. There is typically considerable desmoplasia or formation of a dense fibrous stroma or structural tissue consisting of a range of cell types (including myofibroblasts, macrophages, lymphocytes and mast cells) and deposited material (such as type I collagen and hyaluronic acid). [...] This creates a <b>tumor</b> <b>microenvironment</b> that is short of blood vessels (hypovascular) and so of oxygen (tumor hypoxia). [...] It is thought that this prevents many chemotherapy drugs from reaching the tumor, as one factor making the cancer especially hard to treat.|$|E
40|$|Periostin is {{a crucial}} {{extracellular}} remodeling factor in the inflammatory and <b>tumor</b> <b>microenvironments,</b> but its function in nonalcoholic fatty liver disease remains unclear. Lu et al. (2014) now demonstrate that periostin is a critical player in the regulation of hepatic triglyceride homeostasis {{and the development of}} obesity-induced hepatosteatosis...|$|R
40|$|The {{mechanisms}} by which <b>tumor</b> <b>microenvironments</b> modulate nucleic acid-mediated innate immunity remain unknown. Here, we identified the receptor TIM- 3 as key to circumventing the stimulatory effects of nucleic acids in tumor immunity. TIM- 3 is highly expressed on tumor-associated dendritic cells (DC) in murine tumors and cancer patients. DC-derived TIM- 3 suppresses innate immune responses through Toll-like receptor and cytosolic sensor recognition of nucleic acids via a galectin- 9 independent mechanism. Instead, TIM- 3 interacts with the HMGB 1 to interfere with recruitment of nucleic acids into DC endosomes and attenuates the therapeutic efficacy of DNA vaccination and chemotherapy by reducing immunogenicity of nucleic acids released from dying tumor cells. Together, these findings define a novel mechanism by which <b>tumor</b> <b>microenvironments</b> suppress antitumor immunity mediated by nucleic acids...|$|R
30|$|Alteration or {{disruption}} of stigmergic cues that neoplasia uses {{to assist in}} collaboration in <b>tumor</b> <b>microenvironments</b> through manipulation of morphogenic fields. Such fields are large-scale systems of physical properties that may store patterning information and guide tissue repair and cancer suppression. The use of endogenous bioelectric signals to exert control has been proposed [121].|$|R
2500|$|Wirtz’s lab {{identified}} {{fundamental differences}} between conventional 2D migration and more physiologically relevant 3D migration in cancer cells, creating {{new understanding of}} the <b>tumor</b> <b>microenvironment</b> and metastasis. [...] In particular, {{they found that the}} nucleus, focal adhesion molecules, the lamina, LINC complexes, and matrix metalloproteinase (MMPs) {{play a central role in}} 3D migration (migration in 3D collagen-rich matrices) that is not predicted or extrapolated from the better known 2D case (use of a Petri dish).|$|E
2500|$|Radiotherapy {{is given}} after surgery {{to the region}} of the tumor bed and {{regional}} lymph nodes, to destroy microscopic tumor cells that may have escaped surgery. It may also have a beneficial effect on <b>tumor</b> <b>microenvironment.</b> Radiation therapy can be delivered as external beam radiotherapy or as brachytherapy (internal radiotherapy). Conventionally radiotherapy is given after the operation for breast cancer. [...] Radiation can also be given at the time of operation on the breast cancer. Radiation can reduce the risk of recurrence by 50–66% (1/2 – 2/3 reduction of risk) when delivered in the correct dose and is considered essential when breast cancer is treated by removing only the lump (Lumpectomy or Wide local excision).|$|E
50|$|The <b>tumor</b> <b>microenvironment</b> {{contributes}} to tumour heterogeneity.|$|E
40|$|Human sarcoma cell populations {{maintained}} in culture reflect {{to the native}} tumor cells better if the culture retains those nonmalignant cells that comprised the <b>tumor’s</b> <b>microenvironment</b> in vivo [Hu M, et al. Characterization of 11 human sarcoma cell strains. Cancer 2002; 95 : 1569 – 76] and thus provide paracrine growth factors and protection from apoptotic death to the tumor cells. Whereas sarcoma cell cultures obtained through meticulous efforts aimed at {{the elimination of all}} non-malignant cells of the <b>tumor’s</b> original <b>microenvironment</b> consist of subpopulations of tumor cells growing exclusively with the support of their own autocrine growth loops [Sinkovics JG, et al. Growth of human tumor cells in establishe...|$|R
40|$|Periostin(POSTN) 作为一种重要的细胞外基质蛋白在炎症微环境及肿瘤微环境中都具有重要调控作用。之前的研究表明，POSTN参与了肝脏炎症、纤维化、非酒精性脂肪肝（NAFLD）、非酒精性脂肪肝炎（NASH）及肝癌的发生过程，但对于该蛋白在肝脏再生过程中的功能还有待研究。本论文针对野生型和POSTN敲除型小鼠进行 2 / 3 肝脏局部切除手术，通过肝重比、细胞增殖与血管生成等指标的比较来分析POSTN在肝脏再生中的功能。我们应用免疫组化、qRT–PCR、蛋白印记和ELISA检测POSTN水平，发现接受肝脏局部切除术的小鼠肝脏，POSTN的m-RNA水平和蛋白水平都有显著升高。与野生型小鼠比较，P [...] . Periostin (POSTN) is {{a crucial}} {{extracellular}} remodeling protein in the inflammatory and <b>tumor</b> <b>microenvironments</b> that has been implicated in the pathogenesis of hepatic inflammation, fibrosis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and liver cancer. However, the role of POSTN in liver regeneration remains unclear. Wild-type and POSTN-knockout mice were subje [...] . 学位：理学博士院系专业：生命科学学院_细胞生物学学号： 2162012015380...|$|R
40|$|Although recent evidences {{have been}} {{unveiling}} {{the critical role}} of <b>tumor</b> <b>microenvironments</b> in <b>tumor</b> progression and metastasis, it remains unclear how resistance to various anticancer modalities is linked with the modulation of <b>tumor</b> <b>microenvironments.</b> We identified a novel mechanism whereby constitutively activated DNA damage signals in anticancer therapy-resistant tumor cells suppress antitumor immunity in an integrin-αvβ 3 -dependent manner. Integrin-αvβ 3 was upregulated on various therapy-resistant tumor cells through chronic activation of ATM/chk 2 -and NF-κB-mediated pathways. The inhibition of tumor-specific integrin-αvβ 3 improved therapeutic efficacies of anticancer drugs by stimulating endogenous host immune systems. As a mechanism of action, tumor-specific integrin-αvβ 3 targets dendritic cells to facilitate phagocytosis of live resistant tumor cells, leading to impaired cross-priming of antigen-specific T lymphocytes. Our findings clarified the detrimental effects of DNA damage signals in chemosensitivity and antitumor immunity, and targeting integrin-αvβ 3 has a major implication for treating patient refractory to current anticancer regimens...|$|R
5000|$|... #Caption: Effects of hypoxic <b>tumor</b> <b>microenvironment</b> on {{intracellular}} pH ...|$|E
5000|$|... {{complexity}} of cellular interactions and cell signaling within the <b>tumor</b> <b>microenvironment</b> ...|$|E
50|$|His lab {{focuses on}} researching the <b>tumor</b> <b>microenvironment</b> {{and its role}} in metastasis.|$|E
40|$|In {{the field}} of human cancer research, even though the vast {{majority}} attentions were paid to tumor cells as “the seeds”, the roles of <b>tumor</b> <b>microenvironments</b> as “the soil” are gradually explored in recent years. As a dominant compartment of <b>tumor</b> <b>microenvironments,</b> cancer-associated fibroblasts (CAFs) were discovered to correlated with tumorigenesis, tumor progression and prognosis. And {{the exploration of the}} mechanisms of CAF phenotype transformation would conducive to the further understand of the CAFs function in human cancers. As we known that CAFs have four main origins, including epithelial cells, endothelial cells, mesenchymal stem cells (MSCs) and local mesenchymal cells. However, researchers found that all these origins finally conduct similiar phenotypes from intrinsic to extrinsic ones. Thus, what and how a mechanism can conduct the phenotype transformation of CAFs with different origins? Two viewpoints are proposed to try to answer the quetsion, involving genetic alterations and epigenetic modifications. This review will systematically summarize the advancement of mechanisms of CAF phenotype transformations in the aspect of genentic and epigenetic modifications...|$|R
40|$|<b>Tumor</b> <b>microenvironments</b> present {{significant}} {{barriers to}} anti-tumor agents. Molecules involved in multicellular <b>tumor</b> <b>microenvironments,</b> however, {{are difficult to}} study ex vivo. Here, we generated a matrix-free tumor spheroid model using the NCI-H 226 mesothelioma cell line and compared the gene expression profiles of spheroids and monolayers using microarray analysis. Microarray analysis revealed that 142 probe sets were differentially expressed between tumor spheroids and monolayers. Gene ontology analysis revealed that upregulated genes were primarily related to immune response, wound response, lymphocyte stimulation and response to cytokine stimulation, whereas downregulated genes were primarily associated with apoptosis. Among the 142 genes, 27 {{are located in the}} membrane and related to biologic processes of cellular movement, cell-to-cell signaling, cellular growth and proliferation and morphology. Western blot analysis validated elevation of MMP 2, BAFF/BLyS/TNFSF 13 B, RANTES/CCL 5 and TNFAIP 6 /TSG- 6 protein expression in spheroids as compared to monolayers. Thus, we have reported the first large scale comparison of the transcriptional profiles using an ex vivo matrix-free spheroid model to identify genes specific to the three-dimensional biological structure o...|$|R
40|$|The aim of {{our study}} was to monitor pH of urine samples (< 100 µL) and of tumor microenviron-ments of anesthetized rats in a minimal {{invasive}} way. The small urine volumes of rats or mice make pH measurements difficult, as standard pH electrodes usually need a minimal volume of several milliliters to function. However, the amount of rat urine obtained is frequently < 100 µL, as in our study. Additionally, in vivo pH monitoring of <b>tumor</b> <b>microenvironments</b> is technically quite challeng-ing. The PreSens Manual Micromanipulator (MM) together with a needle-type (NTH) pH Microsensor offered a simple and effective way to do so. Our results show that pH of urine and <b>tumor</b> <b>microenvironments</b> was lower in tumor bearing rats compared to healthy individuals and tissues. Solid tumors contain various cell types, such as cancer-, stromal-, or immune cells, but also proteins and various chemical messengers [1]. The interaction between these cells form the unique tumor micromenvironment and influence both tumor growth and development [2]. As a result, pH differences have been observed in the tumor micorenvironment. While the extracellular pH of malignan...|$|R
50|$|PIK3CA {{participates in}} a complex {{interaction}} within the <b>tumor</b> <b>microenvironment</b> in this phenomenon.|$|E
5000|$|Primary {{human lung}} tumor xenografts that {{preserve}} the <b>tumor</b> <b>microenvironment</b> during long-term engraftment ...|$|E
50|$|Most tumors elicit {{an immune}} {{response}} in the host that is mediated by tumor antigens, thus distinguishing the tumor from other non-cancerous cells. This causes large numbers of tumor-infiltrating lymphocytes (TILs) {{to be found in}} the <b>tumor</b> <b>microenvironment.</b> Although it is not entirely understood, it is thought that these lymphocytes target cancerous cells and therefore slow or terminate the development of the tumor. However, this process is complicated because Tregs seem to be preferentially trafficked to the <b>tumor</b> <b>microenvironment.</b> While Tregs normally make up only about 4% of CD4+ T cells, they can make up as much as 20-30% of the total CD4+ population around the <b>tumor</b> <b>microenvironment.</b>|$|E
40|$|In <b>tumor</b> <b>microenvironments,</b> the {{macrophage}} {{population is}} heterogeneous, but some macrophages can acquire tumor-promoting characteristics. These tumor-associated macrophages (TAM) exhibit an M 2 -like profile, with deficient production of NO and ROS, characteristics of pro-inflammatory M 1 cytotoxic macrophages. The results show an unexpected effect of lipoxin, which induces in TAM {{a change from}} an M 2 - to an M 1 -like profile, thereby triggering tumor cell apoptosis and down-modulating the tumor progression...|$|R
40|$|Identifying novel cancer {{biomarkers}} {{is important}} for early cancer detection as it can reduce mortality rates. The cancer secretome, the collection of all macromolecules secreted by a tumor cell, alters its composition compared to normal tissue, and this change {{plays an important role}} in the observation of cancer progression. The collection and accurate analysis of cancer secretomes could lead to the discovery of novel biomarkers, thus improving outcomes of cancer treatment. We unexpectedly discovered that enzyme-instructed self-assembly (EISA) of a D-peptide hydrogelator results in nanonets/hydrogel around cancer cells that overexpress ectophosphatases. Here we show that these nanonets are able to rapidly collect proteins in the pericellular space (i. e., near the surface) of cancer cells. Because the secretory substances are at their highest concentration near the cell surface, the use of pericellular nanonets to collect the cancer secretome maximizes the yield and quality of samples, reduces pre-analytical variations, and allows the dynamic profiling of secretome samples. Thus, this new approach has great potential in identifying the heterotypic signaling in <b>tumor</b> <b>microenvironments</b> thereby improving the understanding of <b>tumor</b> <b>microenvironments</b> and accelerating the discovery of potential biomarkers in cancer biology. Data are available via ProteomeXchange with identifier PXD 003924...|$|R
30|$|Cancer cell {{metastasis}} {{is affected}} by the surrounding <b>tumor</b> <b>microenvironments.</b> Metastatic lung cancer cells appear to be able to detect alterations in the environmental cues, so that they successfully migrate to target organs and settle properly [29, 30]. Non-small-cell lung carcinomas (NSCLC) frequently migrate to the contra-lateral lung, the brain and to organs such as adrenal glands, liver and bones [29]. Whether lung cancer cells specifically select susceptible sites in the endothelial lining of blood vessels for docking and penetration into organs is largely unknown.|$|R
50|$|Bodenstine TM, Welch DR. Metastasis {{suppressors}} and the <b>tumor</b> <b>microenvironment.</b> Cancer Microenviron. 2008 Dec;1(1):1-11.|$|E
50|$|Tasquinimod {{is a novel}} small-molecule {{inhibitor}} that targets the <b>tumor</b> <b>microenvironment</b> {{by controlling}} the accumulation and immunosuppressive, pro-angiogenic and pro-metastatic functions of regulatory myeloid cells (also called myeloid-derived suppressor cells). It binds to and inhibits the interactions of S100A9, an immunomodulatory protein that promotes tumor development, influences suppressive and pro-angiogenic cells in the <b>tumor</b> <b>microenvironment,</b> and participates {{in the establishment of}} pre-metastatic niches. Tasquinimod may also target the <b>tumor</b> <b>microenvironment</b> by suppressing the tumor hypoxic response, in which genes involved in the adaptation and survival of cells during hypoxia are induced. Tasquinimod reduces tumor angiogenesis; but its anti-angiogenic effects {{do not appear to be}} linked to vascular endothelial growth factor (VEGF) neutralization or VEGF receptor tyrosine kinase inhibition.|$|E
50|$|The <b>tumor</b> <b>microenvironment</b> has an {{inhibitory}} effect on DNA repair pathways contributing to genomic instability, which promotes tumor survival, proliferation, and malignant transformation.|$|E
40|$|One of {{the most}} {{effective}} anticancer therapy still remains chemotherapy, however, both used as single agent as in combinational regimens, chemotherapy still encounters the problem of therapeutic resistance. Limitations of chemotherapy have led to the exploration of alternative anti-cancer approaches in order to improve efficacy, such as chemoprevention. Chemopreventive agents interfere with rate limiting steps in tumor progression, such as for example the establishment of a functional tumor vasculature. Currently, there is a large and unfolding picture of rate-limiting steps during tumor progression which can provide us with numerous potential therapeutic targets, where it is becoming increasingly clear both the tumor itself as its microenvironment contribute in these steps. Current research focuses on exploring chemopreventive approaches as part of combination strategies. One {{of the most}} investigated approaches in these combinational strategies is targeting the tumor with chemotherapy together with chemopreventive agents. This thesis explores the use of chemopreventive approaches as monotherapy and in combinational approaches with chemotherapy and explores and discusses their effects on both the tumor as the <b>tumor’s</b> <b>microenvironment.</b> It shows that these combinational approaches hold great promise, if taking both the tumor as the <b>tumor’s</b> <b>microenvironment</b> into account as therapeutic targets. Promotor: C. W. G. M. Löwik, Co-promotor: E. R. van BeekWith summary in Dutc...|$|R
2500|$|Research on thyroid {{cancer has}} elucidated {{the theory that}} paracrine {{signaling}} may aid in creating <b>tumor</b> <b>microenvironments.</b> [...] Chemokine transcription is upregulated when Ras is in the GTP-bound state. [...] The chemokines are then released from the cell, free to bind to another nearby cell. [...] Paracrine signaling between neighboring cells creates this positive feedback loop. [...] Thus, the constitutive transcription of upregulated proteins form ideal environments for tumors to arise. [...] Effectively, multiple bindings of ligands to the RTK receptors overstimulates the Ras-Raf-MAPK pathway, which overexpresses the mitogenic and invasive capacity of cells.|$|R
40|$|A novel {{metabolic}} {{regulatory mechanism}} {{of ovarian cancer}} by omentum adipose-derived stroma cells (O-ASCs) has been discovered. O-ASCs induce survival, migration, and chemoresistance of ovarian cancer cells. However, the underpinning mechanism behind the metabolic modulation was not understood. Here, O-ASCs are shown to promote nitric oxide (NO) homeostasis in ovarian cancers by generating the pool of arginine. Ovarian cancer cells benefit from <b>tumor</b> <b>microenvironment’s</b> elements and expand their growth. In turn, cancer cells modify the elements’ fate to further take advantage of nutrients and resources. A unique combinatory drug treatment is proposed to target O-ASCs-induced chemoresistance of ovarian cancer cells...|$|R
